Antifungal activities of selected Venda medicinal plants against Candida albicans, Candida krusei and Cryptococcus neoformans isolated from South African AIDS patients.

Infection with HIV leads to immunosuppression and up to 90% of HIV infected individuals contract fungal infections of which 10 - 20% die as a direct consequence of these infections. In the present study, 76 extracts from 30 plants used by Venda traditional healers for the treatment of fungal related ailments, were tested for their antifungal activities against clinical isolates of Candida albicans, Candida krusei and Cryptococcus neoformans using the agar diffusion and the microdilution methods. The minimum fungicidal concentrations as well as the time kill curves of the thee most active plants were also determined. Extracts from 25 plants (83.3%) were active against C. albicans, C. krusei or C. neoformans. Thirty two extracts were active against C. neoformans, while 15 were active against C. albicans and 12 were active against C. krusei. Warburgia salutaris, Cassine transvaalensis, Piper capense, Maerua edulis, Pseudolachnostylis maprouneifolia, Berchemia discolor and Lippia javanica were not only inhibitory to fungal growth but also had fungicidal effects against one or all the 3 fungi tested (MIC/MFC between 0.11 and 7.5 mg/ml). Hexane extracts were also active indicating that many of the antifungal components of these plants are non-polar compounds. Time-to- kill experiments indicated an intense time-dependent fungicidal effect against C. albicans, achieving over a 5 h-period a 6 log10-unit decrease in CFU/ml at a concentration of 0.4 mg/ml for W. salutaris. The present study justifies the traditional use of these plants for the treatment of opportunistic infections in the region.

[1]  D. Mabogo The ethnobotany of the Vhavenda , 2012 .

[2]  Nick Hodgin Screening the East , 2011 .

[3]  P. Houghton,et al.  Free radical scavenging activity of crude extracts and 4´-o-methylepigallocatechin isolated from roots of cassine transvaalensis burtt-davy from botswana , 2010 .

[4]  C. Koga‐Ito,et al.  Frequency of Candida spp. in the Oral Cavity of Brazilian HIV-Positive Patients and Correlation with CD4 Cell Counts and Viral Load , 2009, Mycopathologia.

[5]  S. V. van Vuuren,et al.  Antimicrobial activity of South African medicinal plants. , 2008, Journal of ethnopharmacology.

[6]  M. Falavigna,et al.  Candida esophagitis: species distribution and risk factors for infection. , 2008, Revista do Instituto de Medicina Tropical de Sao Paulo.

[7]  K. Arastéh,et al.  Candida infection in HIV positive patients 1985–2007 , 2008, Mycoses.

[8]  Jian Li,et al.  Clinical characteristics of vulvovaginal candidiasis and antifungal susceptibilities of Candida species isolates among patients in southern China from 2003 to 2006 , 2008, The journal of obstetrics and gynaecology research.

[9]  I. Raskin,et al.  A natural history of botanical therapeutics. , 2008, Metabolism: clinical and experimental.

[10]  M. Coogan,et al.  Antifungal activity of the plant Dodonaea viscosa var. angustifolia on Candida albicans from HIV-infected patients. , 2008, Journal of ethnopharmacology.

[11]  Hy Zhang,et al.  In vitro time kill assessment of crude methanol extract of Helichrysum pedunculatum leaves , 2008 .

[12]  S. V. van Vuuren Antimicrobial activity of South African medicinal plants. , 2008, Journal of ethnopharmacology.

[13]  V. Steenkamp,et al.  Screening of Venda medicinal plants for antifungal activity against Candida albicans , 2007 .

[14]  J. Eloff,et al.  Evaluation of Athrixia bush tea for cytotoxicity, antioxidant activity, caffeine content and presence of pyrrolizidine alkaloids. , 2007, Journal of ethnopharmacology.

[15]  K. Wannemuehler,et al.  Population-based surveillance for cryptococcosis in an antiretroviral-naive South African province with a high HIV seroprevalence , 2006, AIDS.

[16]  M. Moshi,et al.  Antifungal activity of some Tanzanian plants used traditionally for the treatment of fungal infections. , 2006, Journal of ethnopharmacology.

[17]  A. Kinghorn,et al.  Prenylated flavonoids from the root bark of Berchemia discolor, a Tanzanian medicinal plant. , 2006, Journal of natural products.

[18]  Jae-Kwan Hwang,et al.  In vitro anticandidal activity of xanthorrhizol isolated from Curcuma xanthorrhiza Roxb. , 2006, The Journal of antimicrobial chemotherapy.

[19]  M. Recio,et al.  Medicinal plants and antimicrobial activity. , 2005, Journal of ethnopharmacology.

[20]  J. Bessière,et al.  Aromatic Plants of Tropical Central Africa. Part XLVII. Chemical and Biological Investigation of Essential Oils of Ocimum Species from Gabon , 2005 .

[21]  J. Eloff,et al.  Antifungal activities of six South African Terminalia species (Combretaceae). , 2005, Journal of ethnopharmacology.

[22]  J. J. Meyer,et al.  Antimicrobial activity, toxicity and the isolation of a bioactive compound from plants used to treat sexually transmitted diseases. , 2005, Journal of ethnopharmacology.

[23]  H. D. de Boer,et al.  Anti-fungal and anti-bacterial activity of some herbal remedies from Tanzania. , 2005, Journal of ethnopharmacology.

[24]  A. Samie,et al.  Activity profiles of fourteen selected medicinal plants from Rural Venda communities in South Africa against fifteen clinical bacterial species , 2005 .

[25]  A. Elujoba,et al.  TRADITIONAL MEDICINE DEVELOPMENT FOR MEDICAL AND DENTAL PRIMARY HEALTH CARE DELIVERY SYSTEM IN AFRICA. , 2004 .

[26]  M. Pfaller,et al.  Rare and Emerging Opportunistic Fungal Pathogens: Concern for Resistance beyond Candida albicans and Aspergillus fumigatus , 2004, Journal of Clinical Microbiology.

[27]  A. Jäger,et al.  In vitro antibacterial activity of Venda medicinal plants , 2003 .

[28]  J. van Staden,et al.  Screening of traditionally used South African plants for antifungal activity against Candida albicans. , 2003, Journal of ethnopharmacology.

[29]  Q. Karim Trends in HIV/AIDS infection: Beyond current statistics , 2000 .

[30]  J. van Staden,et al.  Isolation of an antibacterial sesquiterpenoid from Warburgia salutaris. , 2000, Journal of ethnopharmacology.

[31]  J. van Staden,et al.  Plant part substitution--a way to conserve endangered medicinal plants? , 2000, Journal of ethnopharmacology.

[32]  J. van Staden,et al.  Preliminary screening of some traditional zulu medicinal plants for anti-inflammatory and anti-microbial activities. , 1999, Journal of ethnopharmacology.

[33]  C. Menut,et al.  Aromatic plants of tropical central Africa. Part XXXII. Chemical composition and antifungal activity of thirteen essential oils from aromatic plants of Cameroon , 1998 .

[34]  D. Debruyne Clinical Pharmacokinetics of Fluconazole in Superficial and Systemic Mycoses , 1997, Clinical pharmacokinetics.

[35]  M. Fatope,et al.  BIOACTIVITIES OF SOME SAVANNA PLANTS IN THE BRINE SHRIMP LETHALITY TEST AND IN VITRO ANTIMICROBIAL ASSAY , 1997 .

[36]  Tong-bin Chen,et al.  Capentin : a novel sesquiterpene from the roots of Piper capense , 1992 .

[37]  R. Eng,et al.  Development of resistance in candida isolates from patients receiving prolonged antifungal therapy , 1991, Antimicrobial Agents and Chemotherapy.

[38]  M. Gundidza,et al.  Antimicrobial activities of ziziphus abyssinica and berchemia discolor. , 1991, The Central African journal of medicine.

[39]  D. Wiemer,et al.  Four neolignan ketones fromPiper capense , 1991 .

[40]  I. Kubo,et al.  Polygodial, an antifungal potentiator. , 1988, Journal of natural products.

[41]  K. Nakanishi,et al.  Screening of east African plants for antimicrobial activity. I. , 1978 .